section name header

Evidence summaries

Personalised Risk Communication for Informed Decision Making About Taking Screening Tests

Personalised risk communication may have a small effect on increasing uptake of screening tests. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 22 studies. There was weak evidence, consistent with a small effect, that personalised risk communication (whether written, spoken or visually presented) increases uptake of screening tests (odds ratio [OR] 1.31, 95% confidence interval [CI] 0.98 to 1.77). More detailed personalised risk communication may be associated with a smaller increase in uptake of tests: for personalised risk communication which used and presented numerical calculations of risk, the OR for test uptake was 0.82 (95% CI 0.65 to 1.03). For risk estimates or calculations which were categorised into high, medium or low strata of risk, the OR was 1.42 (95% CI 1.07 to 1.89). For risk communication that simply listed personal risk factors the OR was 1.42 (95% CI 0.95 to 2.12).

Comment: The quality of evidence is downgraded by limitations in study quality (inadequate or unclear allocation concealment, inadequate intention-to-treat adherence) and by inconsistency (heterogeneity in interventions and outcomes).

References

  • Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev 2006 Oct 18;(4):CD001865. [PubMed]

Primary/Secondary Keywords